Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bourgon

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Nature Communications|November 21, 2019
Transposable element expression in tumors is associated with immune infiltration and increased antigenicityYu Kong, Christopher M Rose, Ashley A Cass, et al.
Cancer Discovery|November 9, 2019
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15<sup>+</sup> Myofibroblasts as a Determinant of Patient Response to Cancer ImmunotherapyClaudia X Dominguez, Sören Müller, Shilpa Keerthivasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancerKim Walter, Thomas Holcomb, Tom Januario, et al.
Nature|May 13, 2021
Cross-tissue organization of the fibroblast lineageMatthew B Buechler, Rachana N Pradhan, Akshay T Krishnamurty, et al.
Cancer Cell|May 7, 2021
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancerMilena Hornburg, Mélanie Desbois, Shan Lu, et al.
Nature Communications|November 5, 2020
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancerMélanie Desbois, Akshata R Udyavar, Lisa Ryner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio TrialThomas Sandmann, Richard Bourgon, Josep Garcia, et al.
Nature Communications|December 31, 2024
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApolloWilliam John Thrift, Nicolas W Lounsbury, Quade Broadwell, et al.
Science Signaling|August 27, 2011
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancerSusanna Stinson, Mark R Lackner, Alex T Adai, et al.
Nature Communications|September 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancerRadia M Johnson, Xueping Qu, Chu-Fang Lin, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Nature Communications|November 21, 2019
Transposable element expression in tumors is associated with immune infiltration and increased antigenicityYu Kong, Christopher M Rose, Ashley A Cass, et al.
Cancer Discovery|November 9, 2019
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15<sup>+</sup> Myofibroblasts as a Determinant of Patient Response to Cancer ImmunotherapyClaudia X Dominguez, Sören Müller, Shilpa Keerthivasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancerKim Walter, Thomas Holcomb, Tom Januario, et al.
Nature|May 13, 2021
Cross-tissue organization of the fibroblast lineageMatthew B Buechler, Rachana N Pradhan, Akshay T Krishnamurty, et al.
Cancer Cell|May 7, 2021
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancerMilena Hornburg, Mélanie Desbois, Shan Lu, et al.
Nature Communications|November 5, 2020
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancerMélanie Desbois, Akshata R Udyavar, Lisa Ryner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio TrialThomas Sandmann, Richard Bourgon, Josep Garcia, et al.
Nature Communications|December 31, 2024
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApolloWilliam John Thrift, Nicolas W Lounsbury, Quade Broadwell, et al.
Science Signaling|August 27, 2011
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancerSusanna Stinson, Mark R Lackner, Alex T Adai, et al.
Nature Communications|September 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancerRadia M Johnson, Xueping Qu, Chu-Fang Lin, et al.
Pageof 6